UK co-ordinating investigator international clinical trial: Idelalisib Combination Study GS-US-401-1757: A Phase 1b Dose Escalation and Dose Expansion Study of ONO/GS-4059 in Combination with other Targeted Anti-cancer Therapies in Subjects with B-cell Malignancies
- Kim Linton (Other)
Activity: Internal positions, career professional development, other peer review and other › Other › Research